Mots-clés
BDSP5 Thésaurus > Groupe population > Toxicomane
ToxicomaneSynonyme(s)Usager de drogue intraveineuseVoir aussi |
Documents disponibles dans cette catégorie (905)
Article
M. SURESH KUMAR ; D. DANIELS ; Alan-I LESHNER, préf. ; S. MUDALIAR ; Sahai Trust. Madras. IND |[BDSP. Notice produite par INIST 3R0xyEr1. Diffusion soumise à autorisation]. Objective. Community-based outreach to drug injectors is an important component of human immunodeficiency virus (HIV) prevention strategy. The purpose of this chapter [...]Article
D.S. METZGER ; Alan-I LESHNER, préf. ; H. NAVALINE ; G.E. WOODY ; Opiate and Aids Research Division of the University of Pennsylvania. Va Medical Center. Center for Studies of Addiction. USA |[BDSP. Notice produite par INIST R0x8ga1P. Diffusion soumise à autorisation]. Objective. As the acquired immunodeficiency syndrome (AIDS) epidemic among drug users enters its third decade in the United States, it is important to consider the rol[...]Article
R. BROONER ; P. BEILENSON ; M. KIDORF ; V. KING ; Alan-I LESHNER, préf. ; D. SVIKIS ; D. VLAHOV ; Department of Psychiatry and Behavioral Sciences. Som. USA |[BDSP. Notice produite par INIST R0xVY5p7. Diffusion soumise à autorisation]. Objective. Although lowering incidence rates of human immunodeficiency virus (HIV) transmission is the primary goal of needle exchange programs (NEPs), other desirable[...]Article
R.E. BOOTH ; M.Y. IGUCHI ; D. JOHN ; C. KWIATKOWSKI ; Alan-I LESHNER, préf. ; F. PINTO ; Department of Psychiatry at the University of Colorado School of Medicine. USA |[BDSP. Notice produite par INIST W8irxR0x. Diffusion soumise à autorisation]. Objectives. High risk injection practices are common among injecting drug users (IDUs), even following intervention efforts. Moreover, relapse to risk behaviors has be[...]Article
D.C.D. JARLAIS ; S.R. FRIEDMAN ; Alan-I LESHNER, préf. ; National Research and Development Institutes. Inc. USA |[BDSP. Notice produite par INIST wnVbSR0x. Diffusion soumise à autorisation]. Objective. Acquired immunodeficiency syndrome (AIDS) was formally identified among injecting drug users (IDUs) in 1981, and research on preventing human immunodeficien[...]Article
R.S. BROADHEAD ; D.L. ANTHONY ; D.D. HECKATHORN ; J. HUGHES ; Alan-I LESHNER, préf. ; H. MADRAY ; R.J. MILLS ; D.L. WEAKLIEM ; University of Connecticut. USA |[BDSP. Notice produite par INIST 8R0xXIpw. Diffusion soumise à autorisation]. Objective. Since 1985, community outreach efforts to combat acquired immunodeficiency syndrome (AIDS) among injecting drug users (IDUs) in the United States have overw[...]Article
A.L. BALL ; K.L. DEHNE ; Alan-I LESHNER, préf. ; S. RANA ; Programme on Substance Abuse. Division of Mental Health and Prevention of Substance Abuse. World Health Organization. Geneva. CHE |[BDSP. Notice produite par INIST AF8R0xvI. Diffusion soumise à autorisation]. Objectives. Human immunodeficiency virus (HIV) infection associated with injecting drug use has been reported in at least 98 countries and territories worldwide. There[...]Article
R.H. NEEDLE ; H. CESARI ; S.L. COYLE ; E. Lambert ; Alan-I LESHNER, préf. ; J. NORMAND ; National Institute on Drug Abuse Nida. USA |[BDSP. Notice produite par INIST R0xc00vK. Diffusion soumise à autorisation].Article
D.M. HARTEL ; Alan-I LESHNER, préf. ; E.E. SCHOENBAUM |[BDSP. Notice produite par INIST R0xYjmcn. Diffusion soumise à autorisation]. Objectives. We undertook a study of the role of methadone maintenance in protecting injecting drug users (IDUs) from human immunodeficiency virus (HIV) infection from [...]Article
S.L. COYLE ; Alan-I LESHNER, préf. ; R.H. NEEDLE ; J. NORMAND ; National Institute on Drug Abuse Nida. USA |[BDSP. Notice produite par INIST 1R0xC441. Diffusion soumise à autorisation]. Objectives. Over the past decade, a body of observational research has accrued about the effects of outreach-based human immunodeficiency virus (HIV) interventions for[...]Article
C.A. LATKIN ; Alan-I LESHNER, préf. |[BDSP. Notice produite par INIST R0x9E4iT. Diffusion soumise à autorisation]. Objective. Guided by a social influence and empowerment framework, peer leaders in the injecting drug user (IDU) community were trained to promote human immunodeficien[...]Article
L.B. COTTLER ; F. Abram ; ARBI BEN ABDALLAH . (.) ; W.M. COMPTON ; R. CUNNINGHAM-WILLIAMS ; W. DOTSON ; C. FICHTENBAUM ; Alan-I LESHNER, préf. ; Department of Psychiatry. Wusm. USA |[BDSP. Notice produite par INIST bBDz8R0x. Diffusion soumise à autorisation]. Objective. The purpose of this chapter is to describe the results of a randomized study (funded by the National Institute on Drug Abuse [NIDA]) comparing a peer-delive[...]Article
M. SINGER ; H.A. BAER ; S. HOROWITZ ; Alan-I LESHNER, préf. ; G. SCOTT ; B. WEINSTEIN ; Hispanic Health Council. ESP |[BDSP. Notice produite par INIST L52hR0xJ. Diffusion soumise à autorisation]. Objective. To break the link between drug use and the human immunodeficiency virus (HIV), in 1992 the state of Connecticut rescinded a 14-year ban on pharmacy sales of[...]Article
T.W. Valente ; R.K. FOREMAN ; B. JUNGE ; Alan-I LESHNER, préf. ; D. VLAHOV ; Epidemiology Department at the Johns Hopkins University School of Public Health. USA |[BDSP. Notice produite par INIST uMR0xfDG. Diffusion soumise à autorisation]. Objective. Our first objective was to develop an index of satellite exchange and then determine whether satellite exchangers (SEs) differed demographically or behavior[...]Article
R. HEIMER ; Alan-I LESHNER, préf. |[BDSP. Notice produite par INIST NR0x9Zpb. Diffusion soumise à autorisation]. Objectives. This chapter attempts to describe the factors influencing the transmission of syringe-borne viruses, to review the effects of syringe exchange programs (SE[...]